日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Safety and efficacy of 24 weeks of pemvidutide in metabolic dysfunction-associated steatotic liver disease: A randomized, controlled clinical trial

为期 24 周的培维度肽治疗代谢功能障碍相关脂肪肝的安全性和有效性:一项随机对照临床试验

Browne, Sarah K; Suschak, John J; Tomah, Shaheen; Gutierrez, Julio A; Yang, Jay; Georges, Bertrand; Roberts, M Scot; Harris, M Scott

The role of vaccination route with an adenovirus-vectored vaccine in protection, viral control, and transmission in the SARS-CoV-2/K18-hACE2 mouse infection model

在SARS-CoV-2/K18-hACE2小鼠感染模型中,腺病毒载体疫苗接种途径在保护、病毒控制和传播中的作用

Dickson, Alexandria; Geerling, Elizabeth; Stone, E Taylor; Hassert, Mariah; Steffen, Tara L; Makkena, Taneesh; Smither, Madeleine; Schwetye, Katherine E; Zhang, Jianfeng; Georges, Bertrand; Roberts, M Scot; Suschak, John J; Pinto, Amelia K; Brien, James D

Induced protection from a CCHFV-M DNA vaccine requires CD8+ T cells

CCHFV-M DNA 疫苗诱导的保护作用需要 CD8+ T 细胞

Joseph W Golden, Collin J Fitzpatrick, John J Suschak, Tamara L Clements, Keersten M Ricks, Mariano Sanchez-Lockhart, Aura R Garrison

A DNA vaccine targeting VEE virus delivered by needle-free jet-injection protects macaques against aerosol challenge.

通过无针喷射注射方式接种的针对委内瑞拉马脑炎病毒的DNA疫苗可保护猕猴免受气溶胶攻击

Suschak John J, Bixler Sandra L, Badger Catherine V, Spik Kristin W, Kwilas Steven A, Rossi Franco D, Twenhafel Nancy, Adams Melissa L, Shoemaker Charles J, Spiegel Erin, Hooper Jay W

A single intranasal administration of AdCOVID protects against SARS-CoV-2 infection in the upper and lower respiratory tracts

一次鼻腔内注射 AdCOVID 可预防上、下呼吸道 SARS-CoV-2 感染

Michael D Schultz, John J Suschak, Davide Botta, Aaron Silva-Sanchez, R Glenn King, Thomas W Detchemendy, Chetan D Meshram, Jeremy B Foote, Fen Zhou, Jennifer L Tipper, Jianfeng Zhang, Kevin S Harrod, Sixto M Leal Jr, Troy D Randall, M Scot Roberts, Bertrand Georges, Frances E Lund

A CCHFV DNA vaccine protects against heterologous challenge and establishes GP38 as immunorelevant in mice

CCHFV DNA 疫苗可抵御异源攻击,并确定 GP38 在小鼠中具有免疫相关性

John J Suschak, Joseph W Golden, Collin J Fitzpatrick, Charles J Shoemaker, Catherine V Badger, Connie S Schmaljohn, Aura R Garrison

Single-Dose Intranasal Administration of AdCOVID Elicits Systemic and Mucosal Immunity against SARS-CoV-2 and Fully Protects Mice from Lethal Challenge

单剂量鼻内给药AdCOVID可诱导针对SARS-CoV-2的全身性和黏膜免疫,并完全保护小鼠免受致命攻击。

King, R Glenn; Silva-Sanchez, Aaron; Peel, Jessica N; Botta, Davide; Dickson, Alexandria M; Pinto, Amelia K; Meza-Perez, Selene; Allie, S Rameeza; Schultz, Michael D; Liu, Mingyong; Bradley, John E; Qiu, Shihong; Yang, Guang; Zhou, Fen; Zumaquero, Esther; Simpler, Thomas S; Mousseau, Betty; Killian, John T Jr; Dean, Brittany; Shang, Qiao; Tipper, Jennifer L; Risley, Christopher A; Harrod, Kevin S; Feng, Tsungwei; Lee, Young; Shiberu, Bethlehem; Krishnan, Vyjayanthi; Peguillet, Isabelle; Zhang, Jianfeng; Green, Todd J; Randall, Troy D; Suschak, John J; Georges, Bertrand; Brien, James D; Lund, Frances E; Roberts, M Scot

Nanoplasmid Vectors Co-expressing Innate Immune Agonists Enhance DNA Vaccines for Venezuelan Equine Encephalitis Virus and Ebola Virus

共表达先天免疫激动剂的纳米质粒载体增强委内瑞拉马脑炎病毒和埃博拉病毒的 DNA 疫苗

John J Suschak, Lesley C Dupuy, Charles J Shoemaker, Carolyn Six, Steven A Kwilas, Kristin W Spik, James A Williams, Connie S Schmaljohn

Vaccines against Ebola virus and Marburg virus: recent advances and promising candidates

埃博拉病毒和马尔堡病毒疫苗:最新进展和有前景的候选疫苗

Suschak, John J; Schmaljohn, Connie S

Advancements in DNA vaccine vectors, non-mechanical delivery methods, and molecular adjuvants to increase immunogenicity

DNA疫苗载体、非机械递送方法和分子佐剂的进步提高了免疫原性

Suschak, John J; Williams, James A; Schmaljohn, Connie S